Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01623479 · ClinicalTrials.gov registry record
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 585
- Enrollment target
NCT01623479 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 585 participants.
The verdict
NCT01623479 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 585 participants
- Enrollment target
Study Summary
This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
Interventions
- DRUG bimatoprost 0.03%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2010-11-19 |
| Est. Completion | 2011-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01623479
The ClinicalTrials.gov registry entry for NCT01623479 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 585 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bimatoprost 0.03% is the first listed.
NCT01623479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01623479 about?
NCT01623479 is a clinical study titled "An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes". This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
What is the current status of trial NCT01623479?
This trial is currently completed. The enrollment target is 585 participants. The study started on 2010-11-19. Estimated completion is 2011-09-01.
What interventions are being tested in trial NCT01623479?
The interventions under investigation include: bimatoprost 0.03% (DRUG).
Who is sponsoring clinical trial NCT01623479?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.